Lv2
170 积分 2025-05-25 加入
Targeting the Pathogenesis of IgA Nephropathy — A New Treatment Approach?
3个月前
已完结
Kidney biopsy in acute kidney injury: increase insight or preserve the status quo?
4个月前
已关闭
Kidney biopsy in acute kidney injury: increase insight or preserve the status quo?
4个月前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
6个月前
已完结
Efficacy and safety of low dose, weight-based subcutaneous enoxaparin protocol in recurrent arteriovenous access thrombosis
9个月前
已完结
A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access
1年前
已完结
皖公网安备34019202002308
